Idiopathic nephrotic syndrome and rituximab: may we predict circulating B lymphocytes recovery?
Jean-Daniel DelbetGael LeclercTim UlinskiPublished in: Pediatric nephrology (Berlin, Germany) (2018)
Once the individual time interval until B cell recovery is determined, monitoring could be individualized by targeting the expected date of B cell recovery or by performing pre-emptive RTX injections.